Howard Gendelman, MD


Dr. Howard E. Gendelman is co-founder of Exavir Therapeutics, and the Margaret R. Larson Professor of Internal Medicine and Infectious Diseases, Chairman of the Department of Pharmacology and Experimental Neuroscience, and Director of the Center for Neurodegenerative Disorders at the University of Nebraska Medical Center. Dr. Gendelman’s work focuses on how the neuroimmune system is involved in metabolic changes and cell damage throughout infectious, metabolic, and neurodegenerative disorders.